Jinhai Medical Technology Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2025. For the period, the company expects to record a loss after taxation of approximately SGD 10.8 million as compared to a loss after taxation for the six month ended 30 June 2024 of approximately SGD 6.0 million. The increase in net loss position for 1H2025 was principally attributable to, amongst others, decrease in gross profit of the Group by approximately SGD 5 million in 1H2025, resulting from the decrease in revenue from the Group's business operation on minimally invasive surgery solution and medical product and related service and dormitory services.